12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, health care stocks saw significant movements. Stoke Therapeutics (STOK) led the gainers with a 77.7% increase following their Q4 earnings report, while Agile Therapeutics (AGRX) experienced the largest drop among the losers, declining by 54.7%. Other notable movers include OpGen (OPGN) with a 66.61% increase and NeuBase Therapeutics (NBSE) with a 54.53% decrease.
March 25, 2024 | 9:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Agile Therapeutics shares plummeted by 54.7% to $0.27 in the after-market session.
The drastic decline in AGRX's stock price suggests negative market reaction, possibly due to disappointing news or performance indicators.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
NeuBase Therapeutics stock fell sharply by 54.53% to $0.45, with a market value of $1.6 million.
The significant drop in NBSE's stock price likely indicates negative market sentiment or reaction to company-specific news.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
OpGen shares increased by 66.61% to $0.79, with a market value of $7.9 million.
OpGen's significant stock price increase could be due to positive developments or expectations, reflected in the market's strong response.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Stoke Therapeutics shares surged 77.7% to $11.55 after their Q4 earnings report.
The significant increase in STOK's stock price is directly attributed to the positive reception of their Q4 earnings report, indicating strong financial performance or outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100